Supreme Court: Companies Cannot Patent Parts of Naturally-Occurring Human Genes

The Associated Press on this Supreme Court ruling:

The Supreme Court ruled Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries.

It’s nice to see some sanity coming out of the US patent system.

See also Germany’s Parliament two months earlier.